Parkinsonian DisordersParkinson Disease, SecondaryParkinson DiseaseParkinson Disease, PostencephaliticLevodopaDihydroxyphenylalanineAntiparkinson AgentsGuadeloupe1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineDyskinesia, Drug-InducedSupranuclear Palsy, ProgressiveHypokinesiaDystoniaMultiple System AtrophyDyskinesiasMPTP PoisoningSubstantia NigraTremorCarbidopaMuscle RigidityGlobus PallidusMovement DisordersTrihexyphenidylLewy Body DiseaseLewy BodiesTauopathiestau ProteinsDopamineCycasOxidopamineUbiquitin-Protein LigasesCorpus Striatumalpha-SynucleinManganese PoisoningBenserazideMMPIOlivopontocerebellar AtrophiesDopamine AgentsBasal Ganglia DiseasesBasal GangliaTropanesDementiaBrainNeurologic ExaminationMyelinolysis, Central PontineGlucosylceramidaseAnnonaceaeAge of OnsetNerve DegenerationPutamenDopaminergic NeuronsTetrabenazineMutationDystonic DisordersExtrapyramidal TractsSynucleinsTyrosine 3-MonooxygenaseDopamine Plasma Membrane Transport ProteinsMucunaSynkinesisDysarthriaChromosomes, Human, Pair 17HallucinationsREM Sleep Behavior DisorderPedigreeOlfaction DisordersAntipsychotic AgentsSculptureWeldingGaucher DiseaseChoreaFrontotemporal DementiaPick Disease of the BrainHypotension, OrthostaticMagnetic Resonance ImagingOrphenadrineHomovanillic AcidAtaxiaDopamine AgonistsNeuronsTranquilizing AgentsGenes, RecessiveBromocriptineDisease Models, AnimalSubthalamic NucleusStereotaxic TechniquesNeurodegenerative Diseases1-Methyl-4-phenylpyridiniumNeurotoxinsAmantadineMesencephalonPrimary DysautonomiasCerebellar AtaxiaApomorphineAnticipation, GeneticMotor ActivityGuamMedicine in ArtTomography, Emission-Computed, Single-PhotonMazindol